Commerce Bank’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$365K	Sell	38,310 -755	-2%	-$5.86K	﹤0.01%	1054
2025 Q4	$305K	Buy	39,065 +9,350	+31%	+$67.6K	﹤0.01%	1076
2025 Q3	$226K	Sell	29,715 -1,625	-5%	-$13.5K	﹤0.01%	1162
2025 Q2	$281K	Hold	31,340	–	–	﹤0.01%	1054
2025 Q1	$235K	Buy	31,340 +290	+0.9%	+$2.34K	﹤0.01%	1090
2024 Q4	$233K	Sell	31,050 -225	-0.7%	-$1.71K	﹤0.01%	1104
2024 Q3	$238K	Sell	31,275 -1,035	-3%	-$7.87K	﹤0.01%	1127
2024 Q2	$200K	Hold	32,310	–	–	﹤0.01%	1154
2024 Q1	$164K	Buy	32,310 +13,645	+73%	+$76.7K	﹤0.01%	1156
2023 Q4	$112K	Sell	18,665 -895	-5%	-$5.19K	﹤0.01%	1157
2023 Q3	$138K	Sell	19,560 -555	-3%	-$3.99K	﹤0.01%	1107
2023 Q2	$142K	Sell	20,115 -250	-1%	-$2.01K	﹤0.01%	1115
2023 Q1	$170K	Buy	20,365 +5,760	+39%	+$55.5K	﹤0.01%	1117
2022 Q4	$168K	Buy	14,605 +4,235	+41%	+$52.8K	﹤0.01%	1087
2022 Q3	$130K	Buy	+10,370	New	+$133K	﹤0.01%	1106
2022 Q2	–	Sell	-20,000	Closed	-$325K	–	1149
2022 Q1	$325K	Hold	20,000	–	–	﹤0.01%	972
2021 Q4	$277K	Buy	20,000 +5,000	+33%	+$66.2K	﹤0.01%	1038
2021 Q3	$216K	Buy	+15,000	New	+$237K	﹤0.01%	1103